Teresa Santantonio

Summary

Affiliation: University of Foggia
Country: Italy

Publications

  1. ncbi request reprint Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B
    Teresa Santantonio
    Clinic of Infectious Diseases, University of Foggia, Ospedali Riuniti, Foggia, Italy
    Antivir Ther 14:557-65. 2009
  2. doi request reprint Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirin
    Teresa Santantonio
    Infectious Diseases, University of Foggia, Foggia, Italy
    Hepatology 59:2101-9. 2014
  3. doi request reprint Acute hepatitis C: current status and remaining challenges
    Teresa Santantonio
    Clinic of Infectious Diseases, University of Bari, Policlinico, Bari, Italy
    J Hepatol 49:625-33. 2008
  4. doi request reprint HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years
    Massimo Fasano
    Clinic of Infectious Diseases, University of Bari, Policlinico, Bari, Italy
    J Hepatol 56:1254-8. 2012
  5. ncbi request reprint Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance
    Teresa Santantonio
    Clinic of Infectious Diseases, University of Bari, Policlinico, Piazza Giulio Cesare 11, 70124 Bari, Italy
    J Hepatol 42:329-33. 2005

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B
    Teresa Santantonio
    Clinic of Infectious Diseases, University of Foggia, Ospedali Riuniti, Foggia, Italy
    Antivir Ther 14:557-65. 2009
    ..Risk factors for ADV resistance were also evaluated...
  2. doi request reprint Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirin
    Teresa Santantonio
    Infectious Diseases, University of Foggia, Foggia, Italy
    Hepatology 59:2101-9. 2014
    ..6%, 81.6%, and 81.6% for patients in arms 1, 2, and 3 respectively. With multivariate analysis, virologic response at week 4 of treatment was an independent predictor of SVR. Peg-IFN alpha-2b was well tolerated...
  3. doi request reprint Acute hepatitis C: current status and remaining challenges
    Teresa Santantonio
    Clinic of Infectious Diseases, University of Bari, Policlinico, Bari, Italy
    J Hepatol 49:625-33. 2008
    ..We also discuss data from published clinical studies and focus on unresolved issues for which additional studies are needed in order to establish standardized treatment guidelines for the management of acute hepatitis C...
  4. doi request reprint HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years
    Massimo Fasano
    Clinic of Infectious Diseases, University of Bari, Policlinico, Bari, Italy
    J Hepatol 56:1254-8. 2012
    ..This study aims at assessing LAM efficacy over a 5-year period and the residual risk of drug resistance. The rate of HBsAg clearance and LAM long-term safety profile were also evaluated...
  5. ncbi request reprint Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance
    Teresa Santantonio
    Clinic of Infectious Diseases, University of Bari, Policlinico, Piazza Giulio Cesare 11, 70124 Bari, Italy
    J Hepatol 42:329-33. 2005
    ....